Narrow your search

Library

ULB (4)

EhB (3)

KU Leuven (3)

LUCA School of Arts (3)

Odisee (3)

Thomas More Kempen (3)

Thomas More Mechelen (3)

UCLL (3)

ULiège (3)

VDIC (3)

More...

Resource type

book (5)


Language

English (4)

French (1)


Year
From To Submit

2005 (5)

Listing 1 - 5 of 5
Sort by
Principles of pharmacology : the pathophysiologic basis of drug therapy
Author:
ISBN: 0781746787 Year: 2005 Publisher: Baltimore : Lippincott Williams & Wilkins,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Combination Cancer Therapy : Modulators and Potentiators
Author:
ISBN: 9781588292001 1588292002 9781592598649 9786610359516 128035951X 1592598641 162703806X Year: 2005 Publisher: Totowa, NJ : Humana Press : Imprint: Humana,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer Therapy: Modulators and Potentiators, expert physician-scientists and clinicians with first-hand experience in the clinical development of targeted therapies review those combinations that hold the most promise for the future of medical oncology, detailing their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory benchtop to the patient's bedside as a new generation of cancer therapeutics. Cutting-edge and forward-looking, Combination Cancer Therapy: Modulators and Potentiators offers everyone in the fields of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects for cancer patients today.

Thrombolytic Therapy for Acute Stroke
Author:
ISBN: 9781588293985 158829398X 9781592599332 9786610359011 1280359013 1592599338 Year: 2005 Publisher: Totowa, NJ : Humana Press : Imprint: Humana,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Now extensively revised and significantly expanded, this second edition of the highly praised Thrombolytic Therapy for Stroke incorporates the knowledge gained from the widespread implementation of large rt-PA for acute stroke trials and demonstrates the power of the new technologies now available, specifically MRI scanning. The authors, all recognized experts internationally known for their contributions to developing thrombolytic therapy, have included much new material on stroke-MRI and computed tomography, and updated all chapters describing the background, use, and nuances of thrombolytic therapy. They present everything one needs to know for proper patient selection, the key to successful treatment. Practical how-to chapters guide the reader in treating acute stroke patients, both with and without thrombolytic therapy, according to the latest findings. As in the first edition, all the facts and data are presented for the reader to consider, with opinion clearly segregated and labeled. New detailed practice cases simulate making the rounds in a world-class stroke center to prepare practitioners to be as ready as possible for their first case. Up to date and highly practical, Thrombolytic Therapy for Acute Stroke, Second Edition offers the practicing physician everything necessary-background, protocols, new technologies, and case studies-for the safe and effective treatment of the emergency stroke patient today.

Camptothecins in Cancer Therapy
Author:
ISBN: 9781588290274 1588290271 9781592598663 9786610359509 1280359501 1592598668 1627038167 Year: 2005 Publisher: Totowa, NJ : Humana Press : Imprint: Humana,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critically review our current understanding of camptothecins, their shortcomings, and the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers. Additional chapters describe what is known about the biochemistry, the pharmacology, and the chemistry of the camptothecins, including the mechanism of topoisomerase and how camptothecins poison this enzyme, the use of animal models in defining the anticancer potential of camptothecins, and the question of camptothecin resistance. Authoritative and up-to-date, Camptothecins in Cancer Therapy provides a comprehensive summary of camptothecin research, as well as a much-needed guide to all the latest information on their optimal therapeutic applications.

Listing 1 - 5 of 5
Sort by